[CLSTR]
API
< Back to situations

Monitor this situation.

[SITUATION] · [ACTIVE] · [HEALTH]

45 clusters · 162 sources · 158 days · First seen · Last updated

Global RSV vaccine and antibody rollout expands

Overview

Global RSV immunization and antibody rollouts continue to expand, showing significant clinical impact. In the UK, maternal vaccination led to a 50% reduction in intensive care or high dependency unit admissions for infants under six months during the 2025-26 season. In Spain, research from Hospital Joan XXIII confirmed that the monoclonal antibody nirsevimab reduces bronchiolitis hospitalizations in infants under six months by 80%. Regional efforts in Spain have intensified; Andalusia has invested 15.2 million euros to immunize approximately 55,000 infants, while Castilla-La Mancha has also allocated funds for respiratory disease prevention.

In Europe, Sweden has expanded antibody treatments to all newborns, following a successful rollout in the Halland region that saw an 82% drop in hospitalizations. Italy has begun the rollout of clesrovimab, which has received European Commission authorization for use across 27 EU member states, Iceland, Liechtenstein, and Norway. Croatia’s Health Insurance Fund (HZZO) has approved funding for long-acting monoclonal antibodies to protect all children entering their first RSV season. Ireland has launched an immunization program via maternity hospitals and GPs, noting that nirsevimab can prevent up to 80% of RSV-related hospitalizations.

In the Americas, Panama has launched a $3.5 million initiative to administer nirsevimab to newborns. In Canada, a study across seven pediatric hospitals estimated nirsevimab provides approximately 77% protection against emergency room visits and 97% protection against intensive care unit admission. Canadian provinces show varying coverage; New Brunswick has expanded free immunization to all newborns, while Alberta and British Columbia maintain specific age and risk-based criteria for adults.

To improve global access, the WHO has prequalified the multi-dose vial presentation of the maternal RSV vaccine, RSVpreF, to increase affordability in low- and middle-income countries.

Entities

Respiratory Syncytial Virus · nirsevimab · Junta de Andalucía · World Health Organization · Ireland

Claims

What the coverage asserts, and how many sources carry each claim.

Timeline

  1. [HEALTH] 3 sources
    Respiratory Syncytial Virus vaccination campaigns expand in Argentina and Peru

    Argentina and Peru are utilizing maternal RSV vaccination campaigns to reduce infant hospitalizations and intensive care admissions by transferring antibodies to newborns.

  2. [HEALTH] 2 sources
    Canadian provinces implement varying RSV vaccine coverage for 2026

    Canadian provinces are rolling out RSV vaccine programs for 2026 with varying age limits and eligibility rules for high-risk groups and Indigenous populations.

  3. [HEALTH] 3 sources
    HSE Ireland launches RSV immunisation programme for infants

    Ireland's HSE is rolling out RSV immunisation for infants to reduce hospital admissions, alongside ongoing HPV catch-up programmes and seasonal health guidance.

  4. [HEALTH] 6 sources
    Portugal vaccinates 31,000 children against RSV in first month

    Portugal's RSV vaccination campaign has reached 31,000 children in its first month, aiming to protect 84,000 eligible infants and reduce hospitalizations.

  5. [HEALTH] 9 sources
    Clesrovimab approved in Italy to prevent RSV in newborns

    Italy has approved clesrovimab, a long-acting monoclonal antibody, to prevent RSV-related respiratory diseases in newborns using a single, weight-independent dose.

  6. [HEALTH] 6 sources
    Andalucía implements advanced vaccination program and RSV campaign

    Andalucía has launched an RSV immunization campaign for over 55,000 infants, utilizing nirsevimab monoclonal antibodies as part of a vaccination schedule recognized as one of Europe's most advanced.

  7. [HEALTH] 2 sources
    New Brunswick expands free RSV immunization to all newborns

    New Brunswick is providing free RSV immunization to all newborns, while health experts warn of the upcoming respiratory virus season, noting high hospitalization and death rates among vulnerable groups.

  8. [HEALTH] 2 sources
    Nirsevimab shows high efficacy against RSV in Canadian infant study

    A Canadian study shows the monoclonal antibody nirsevimab provides up to 79% protection against RSV-related hospitalizations and 97% protection against intensive care admissions in infants.

  9. [HEALTH] 5 sources
    Respiratory infections rise in Altiplano as Andalusia expands RSV immunization

    Respiratory infections are rising sharply in Spain's Altiplano region, while Andalusia reports progress in its RSV immunization campaign for infants to combat bronchiolitis.

  10. [HEALTH] 5 sources
    RSV surveillance and immunization programs reported in Uganda and Ireland

    Ireland has launched its annual free RSV immunization program for infants, while Uganda reports two RSV infections detected through sentinel hospital respiratory surveillance.

  11. [HEALTH] 2 sources
    Ireland and Alberta expand free RSV immunization access for infants

    Ireland and Alberta are expanding access to free RSV immunizations for infants, utilizing the nirsevimab antibody to reduce hospitalizations and ICU admissions during respiratory virus seasons.

  12. [HEALTH] 19 sources
    Spain launches regional respiratory virus vaccination campaigns

    Spanish regions are launching 2026-2027 vaccination campaigns for influenza, COVID-19, and RSV, with expanded pediatric coverage and significant investments to prevent respiratory illnesses.

  13. [HEALTH] 8 sources
    Croatia to fund RSV immunization for infants

    Croatia will fund RSV immunization for infants this season using long-acting monoclonal antibodies to prevent severe respiratory infections in children during their first RSV season.

  14. [HEALTH] 8 sources
    Spain launches regional RSV and influenza vaccination campaigns

    Spanish regions Andalusia and Castilla-La Mancha have launched vaccination campaigns for RSV and influenza, targeting infants, high-risk groups, and the elderly to prevent seasonal respiratory illnesses.

  15. [HEALTH] 3 sources
    WHO prequalifies multi-dose RSV vaccine for pregnant women

    The WHO has prequalified a multi-dose vial of the RSVpreF vaccine for pregnant women to help reduce infant mortality and hospitalizations caused by Respiratory Syncytial Virus globally.

  16. [HEALTH] 5 sources
    WHO prequalifies multi-dose RSV vaccine to expand global infant protection

    The WHO has prequalified a multi-dose maternal RSV vaccine to improve global access for infants, while new research shows RSV vaccines reduce hospitalizations in seniors by up to 75%.

  17. [HEALTH] 3 sources
    Sweden expands antibody treatments for newborns to combat RS-virus

    Sweden is expanding antibody treatments for newborns to combat the RS-virus, following a successful pilot that reduced RSV-related infant hospitalizations by approximately 82 percent.

  18. [HEALTH] 2 sources
    Belgium health officials recommend RSV antibody treatment for infants

    Belgian health officials recommend Beyfortus, an antibody treatment, to protect infants from severe RSV infections during the upcoming respiratory virus season.

  19. [HEALTH] 2 sources
    Castilla-La Mancha invests 3.2 million euros in RSV protection for infants

    Castilla-La Mancha has contracted Sanofi Aventis for 15,000 doses of nirsevimab to protect infants from severe respiratory syncytial virus (RSV) infections during the 2026-2027 season.

  20. [HEALTH] 9 sources
    Lombardy launches early RSV immunization campaign for newborns

    Lombardy has launched an early immunization campaign providing free monoclonal antibodies to newborns to protect against Respiratory Syncytial Virus (RSV) before the winter season.

  21. [HEALTH] 2 sources
    Panama begins nirsevimab administration to protect newborns from RSV

    Panama has begun administering nirsevimab, a monoclonal antibody, to newborns to prevent severe Respiratory Syncytial Virus (RSV) infections, following a $3.5 million investment for 13,790 doses.

  22. [HEALTH] 5 sources
    Nirsevimab reduces RSV bronchiolitis hospitalizations by 80% in infants

    Research from Hospital Joan XXIII shows the monoclonal antibody nirsevimab reduces RSV-related bronchiolitis hospitalizations by 80% and pediatric ICU admissions by 55% in infants.

  23. [HEALTH] 2 sources
    Vietnam medical experts discuss RSV prevention for infants

    Medical experts in Vietnam are discussing new prevention strategies for RSV, a highly contagious virus that causes severe respiratory infections and is a leading cause of infant hospitalization.

  24. [HEALTH] 2 sources
    Maternal RSV vaccination reduces infant ICU admissions in England

    Maternal RSV vaccination has halved infant intensive care admissions in England, while specialists in Peru urge broader, year-round access to the vaccine for pregnant women.

  25. [HEALTH] 2 sources
    Maternal RSV vaccination reduces infant hospitalizations in Australia and UK

    Maternal RSV vaccination programs in Australia and the UK are significantly reducing infant hospitalizations and intensive care admissions for respiratory syncytial virus.

  26. [HEALTH] 3 sources
    Panama faces RSV surge with 18 deaths and hospital bed shortages

    Panama reports 18 deaths from respiratory syncytial virus (RSV), primarily among children. The Hospital del Niño has suspended elective surgeries due to high hospitalization rates and bed shortages.

  27. [HEALTH] 4 sources
    UK maternal RSV vaccine program halves newborn ICU admissions

    New data from the UK Health Security Agency shows a 50% drop in newborn ICU admissions for RSV in England following the first full year of a maternal vaccination program.

  28. [HEALTH] 2 sources
    Goiânia maintains RSV immunization for high-risk children

    Goiânia is providing RSV immunization for high-risk children with comorbidities until August 31 at the Municipal Vaccination Center to prevent severe respiratory infections.

  29. [HEALTH] 2 sources
    RSV prevention shows high efficacy despite emerging antibody resistance

    New data shows maternal RSV vaccination significantly reduces infant hospitalizations, while studies in France identify emerging nirsevimab resistance in specific RSV-B breakthrough infections.

  30. [HEALTH] 2 sources
    Panama Oeste reports 36 RSV cases, three infants remain hospitalized

    Panama Oeste reports 36 RSV cases, with three infants (2‑8 months) still hospitalized, one transferred to Hospital del Niño in Panama City. Officials urge vaccination for pregnant women and seniors, and stress防

  31. [HEALTH] 2 sources
    Argentina and Mexico expand newborn vaccination programs

    Argentina's Cipolletti hospital schedules weekly BCG shots for newborns, while Mexico's Tamaulipas state offers free RSV vaccine to pregnant women to protect infants at birth.

  32. [HEALTH] 4 sources
    RSV outbreak hospitalizes infants in Panama West province

    Four infants in Panama West are hospitalized with RSV‑related bronchiolitis and pneumonia; 36 provincial cases reported, 13 national deaths this year, and health officials urge maternal vaccination and hygiene.

  33. [HEALTH] 11 sources
    RSV activity surges across Latin America, sparking child deaths in Panama and rising cases in Chile

    RSV caused 13 child deaths in Panama and became Chile's top virus in July 2026, prompting regional vaccination drives and preventive measures.

  34. [HEALTH] 5 sources
    RSV vaccine for pregnant women launched in Ecuador, also in Brazil

    Brazil maintains RSV vaccination for pregnant women, while Ecuador launches the vaccine for the first time, aiming to protect newborns from severe respiratory disease.

  35. [HEALTH] 2 sources
    Portugal study: RSV kills nearly 20% of hospitalized adults

    A Portuguese study of 24,000 adult respiratory admissions (2018‑2024) found RSV caused 2,257 cases, with 48.7% developing respiratory failure and a 17.8% in‑hospital death rate, mainly among patients over 60.

  36. [HEALTH] 2 sources
    Brazil and Argentina roll out Nirsevimab to protect premature infants from RSV

    Brazil’s Várzea Grande and Argentina’s Córdoba municipalities have started free Nirsevimab programs to shield high‑risk infants from severe RSV infections.

  37. [HEALTH] 2 sources
    RSV vaccine cuts elderly hospitalizations by 75% in US study

    US study shows RSV vaccine (Arexvy) reduces elderly hospitalizations by 75.6%, severe cases by 79.1% and deaths by 66.8%; Brazil recommends vaccination for seniors amid rising RSV cases.

  38. [HEALTH] 2 sources
    Dominican Republic launches new monoclonal antibody for RSV and long‑acting HIV injection

    Dominican Republic adds Nirsevimab for RSV protection of high‑risk infants and prepares to roll out bi‑annual Lenacapavir injections for HIV prevention, both offered free in public health facilities.

  39. [HEALTH] 2 sources
    Argentina and Dominican Republic introduce Nirsevimab monoclonal antibody for RSV protection in infants

    Argentina’s San Juan province and the Dominican Republic health ministries have each adopted the monoclonal antibody Nirsevimab, offering season‑long RSV protection to high‑risk infants with a single dose.

  40. [HEALTH] 2 sources
    RSV universal prophylaxis with monoclonal antibody reduces hospitalizations in Italy

    RSV monoclonal‑antibody prophylaxis, now used universally in Italy, offers immediate protection for infants, cutting severe bronchiolitis cases and easing pediatric ICU strain.

  41. [HEALTH] 6 sources
    Australia ramps up RSV vaccination for seniors and expectant mothers

    An Australian asthma patient’s severe RSV case underscores the risk, while the AMA promotes funded RSV vaccines for seniors, Indigenous adults, and pregnant women, citing 587 deaths and a 9% drop in child cases

  42. [HEALTH] 2 sources
    RSV Prevention Advances: South Korea approves MSD's Encloncia; Australia expands vaccine program

    South Korea approves MSD's Encloncia monoclonal antibody for infant RSV prevention; Australia expands RSV vaccine access for seniors, Indigenous adults, and pregnant women during Awareness Week.

  43. [HEALTH] 2 sources
    Australia expands RSV vaccine access for older adults

    Australian pharmacists can give a single‑dose RSV vaccine to adults 60+ without a GP script, protecting older adults for at least two seasons and cutting severe illness risk.

  44. [HEALTH] 2 sources
    RSV Vaccine Reduces Hospital Stays for Seniors in Danish Study

    A Danish study of 131,000 seniors shows the RSVpreF vaccine lowered cardiorespiratory hospitalizations by 9.9%, highlighting broader benefits of RSV prevention for older adults.

  45. [HEALTH] 3 sources
    Italy's RSV vaccine could cut unnecessary antibiotics, says expert Marco Falcone

    Italy's RSV cases lead to 50‑75% unnecessary antibiotic use; expert Marco Falcone urges wider RSV, flu and pneumococcal vaccination to curb resistance.

Sources

24sata.hr · ad-hoc-news.de · ama.com.au · archynewsy.com · asthma.org.au · atentos.cl · atlantico.net · atualidadepolitica.com.br · azsalute.it · bierzodiario.es · bioquicknews.com · boletimgoias.com.br · brasilemfolhas.com.br · canadanewsmedia.ca · canalalentejo.sapo.pt · cmjornal.xl.pt · consalud.es · contemporaryobgyn.net · corcianonline.it · cordoba.gob.ar · correiodamanha.pt · cremonaoggi.it · dailydigest.ie · dailyguardian.ca · dalmacijadanas.hr · destinopanama.com.pa · dgvs.mspbs.gov.py · diaadia.com.pa · diariocorreo.pe · diariodealmeria.es · diariodejerez.es · diariodeleon.es · diariodesalud.com.do · diariodesevilla.es · diariodistrito.sapo.pt · dinheirovivo.pt · dn.se · dnoticias.pt · doctor33.it · ecodeteruel.tv · economis.com.ar · eladelantado.com · elcastillodesanfernando.es · elcomercio.com · elcorreord.com · elcorreoweb.es · eldia.com.do · eldiadecordoba.es

This summary has been updated 24 times: see revision history